Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.

Select to filter on program types

Congress news 14/11/2018

Euretina 2018: News

This Euretina highlight brings you news about: * profilactic laser in AMD * first results of the ALTAIR study and the ARIES study * Elaboration on the PROTOCOL S and CLARITY studies

Congress news 14/11/2018

Euretina 2018: Important developments

This Euretina Highlight brings you news about: * developments after the presentation of the PLACE trial results . * How will eye diseases being diagnosed in the future? * The importance of OCT in CSC. * Neovaslularization and PCV in CSC.

Congress news 22/03/2018

WCM 2017 Highlights: Immunotherapy

The 9th World Congress of Melanoma (WCM) was held in Brisbane, Australia, from 18 to 21 October. In a series of interviews medical professionals from all over the world discussed the latest developments in the field of melanoma. This highlight consists of the following parts: Prof. Caroline Robert, MD – dermatologist, Institute Gustave-Roussy, Paris, France: The latest results of immunotherapy in melanoma Alain Algazi, MD – oncologist, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA: Clinical immune monitoring and biomarker data of pIL-12 monotherapy compared to pIL-12 with pembrolizumab in metastatic melanoma Sapna Patel, MD – oncologist, MD Anderson Cancer Center, Houston, USA: A phase II study of glembatumumab vedotin for metastatic uveal melanoma